Tarsus Pharmaceuticals, Inc. TARS Interest Income
Interest Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeOther.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s interest income?
- Tarsus Pharmaceuticals, Inc. (TARS) reported interest income of $3.72M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s interest income changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s interest income increased by 7.8% year-over-year, from $3.45M to $3.72M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s interest income?
- Over 3 years (2022 to 2025), Tarsus Pharmaceuticals, Inc.'s interest income has grown at a 65.3% compound annual growth rate (CAGR), from $3.49M to $15.75M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.